These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3839208)

  • 1. Effects of natural or synthetic microbial adjuvants on induction of autoimmune thyroiditis.
    Kong YC; Audibert F; Giraldo AA; Rose NR; Chedid L
    Infect Immun; 1985 Jul; 49(1):40-5. PubMed ID: 3839208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
    Jolivet M; Sache E; Audibert F
    Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H; Koga T
    Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.
    Leclerc CD; Audibert FM; Chedid LA; Deriaud EJ; Masihi NK; Lederer E
    Infect Immun; 1984 Mar; 43(3):870-5. PubMed ID: 6698611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
    Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
    Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
    Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I
    Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
    Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
    Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
    Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
    Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species.
    McAdam KP; Foss NT; Garcia C; DeLellis R; Chedid L; Rees RJ; Wolff SM
    Infect Immun; 1983 Mar; 39(3):1147-54. PubMed ID: 6601620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative 1H-n.m.r. study of MurNAc-L-Ala-D-iGln (MDP) and its analogue murabutide: evidence for a structure involving two successive beta-turns in MDP.
    Fermandjian S; Perly B; Level M; Lefrancier P
    Carbohydr Res; 1987 Apr; 162(1):23-32. PubMed ID: 3594477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T; Kotani S; Shimauchi H
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.
    Kohashi O; Aihara K; Ozawa A; Kotani S; Azuma I
    Lab Invest; 1982 Jul; 47(1):27-36. PubMed ID: 7087395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
    Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
    Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives.
    Löwy I; Leclerc C; Chedid L
    Immunology; 1980 Mar; 39(3):441-50. PubMed ID: 6160092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.